C Steven Gilman

Affiliations

  • at Scynexis Inc (SCYX), 2023-06-23
  • at Akebia Therapeutics Inc. (AKBA), 2023-06-08
  • at Vericel Corp (VCEL), 2023-05-05
  • Director at Contrafect Corp (CFRX), 2022-05-18
  • Director at Momenta Pharmaceuticals Inc (MNTA), 2020-10-01
  • Director at Keryx Biopharmaceuticals Inc (KERX), 2018-12-13
  • Evp & Chief Scientific Officer at Cubist Pharmaceuticals Inc (CBST), 2015-01-21
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SCYX $6.25 4,000 Director 4,000 2020-12-21 Filing
AKBA $3.43 5,800 29,731 2019-11-20 Filing
CFRX $1.24 800 Officer, Director 20,800 2017-07-25 Filing
CFRX $2.48 20,000 Officer, Director 20,000 2016-07-27 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AKBA $0.36 4,567 43,430 2022-06-03 Filing
VCEL $30.94 900 5,200 2022-04-29 Filing
VCEL $39.17 5,000 3,500 2021-11-29 Filing
VCEL $50.57 5,000 3,500 2021-10-27 Filing
VCEL $48.85 5,000 3,500 2021-09-30 Filing